(Q40948895)

reason for preferred rank

25 September 2017

Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1α in the rat paw (English)

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

7 April 2023

Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat paw (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360302

7 April 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360302

7 April 2023

prostaglandins F

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360302

7 April 2023

prostacyclin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360302

7 April 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

7 April 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

7 April 2023

3

J. R. Vane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360302

7 April 2023

author name string

E. A. Higgs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360302

7 April 2023

S. Moncada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A360302

7 April 2023

language of work or name

1 reference

1 August 1978

1 reference

full work available at URL

25 September 2017

https://api.elsevier.com/content/article/PII:0090698078900187?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

https://api.elsevier.com/content/article/PII:0090698078900187?httpAccept=text/plain

7 April 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

7 April 2023

1 reference

25 September 2017

16

1 reference

25 September 2017

153-162

1 reference

25 September 2017

2

1 reference

The mode of action of aspirin and similar compounds

25 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

7 April 2023

2

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Aspirin selectively inhibits prostaglandin production in human platelets

7 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Indomethacin and aspirin abolish prostaglandin release from the spleen

7 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Recovery of Prostaglandins in Human Cutaneous Inflammation

7 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Distribution of prostaglandins in inflammatory exudate

7 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Prostaglandins, Aspirin-like Drugs and Analgesia

7 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs

7 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint

7 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Prostaglandin E-1: a potential mediator of the inflammatory response

7 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Prostaglandins as Potentiators of Increased Vascular Permeability in Inflammation

7 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Inflammatory effects of prostaglandin D2 in rat and human skin

7 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

A hypertensive response to infusion of prostaglandin F2α into the vertebral artery of the conscious dog

7 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Actions and interactions of prostaglandins administered intradermally in rat and in man

7 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Prostaglandin F2alpha reduces the algesic effect of bradykinin by antagonizing the pain enhancing action of endogenously released prostaglandin E.

7 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

7 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

The chemical structure of prostaglandin X (prostacyclin)

7 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung

7 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha

7 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

7 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

7 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid

7 April 2023

31

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Prostaglandins, aspirin-like drugs and the oedema of inflammation.

7 April 2023

33

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

Role of prostaglandin-mediated vasodilatation in inflammation

7 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

A new prostaglandin transformed from arachidonic acid in carrageenin-induced granuloma

7 April 2023

35

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

The release of prostaglandins from lung and other tissues

7 April 2023

36

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation

7 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/0090-6980(78)90018-7

7 April 2023

Identifiers

1 reference

25 September 2017

1 reference